1 / 35

Pain – Healing It Without Feeling It

Pain – Healing It Without Feeling It. Elizabeth Weinstein, M.D., M.S. Medical Director Supportive Oncology Seidman Cancer Center UH Case Medical Center. Mariel Harris, M.D., J.D. Medical Director for Senior Services UH Richmond Medical Center

baldasarre
Télécharger la présentation

Pain – Healing It Without Feeling It

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Pain – Healing It Without Feeling It Elizabeth Weinstein, M.D., M.S. Medical Director Supportive Oncology Seidman Cancer Center UH Case Medical Center Mariel Harris, M.D., J.D. Medical Director for Senior Services UH Richmond Medical Center Geriatric Medicine, Hospice & Palliative Care UH Center for Geriatric Medicine Rajesh Chandra, M.D. Division Chief General Internal Medicine & Geriatrics UH Case Medical Center Todd M. Zeiger, M.D. UH Sharon Center Family Medicine Regional Medical Director UH Sharon and Medina Health Center David Cogan, M.D. Senior Medical Director UHMP Helen C. Foley, MSN, RN Adult Oncology CNS Seidman Cancer Center UH Case Medical Center Hildy Pearl, MS, RD, LD Clinical Systems Liaison UH Case Medical Center Robin Rowell, RN, CNP VP, Institute and Medical/Surgical Clinical Operations UH Case Medical Center Kim F. Bixenstine, Esq. Vice President and Deputy General Counsel University Hospitals Debbie Horan, RN, BSN Clinical Systems Liaison UH Case Medical Center

  2. Pain – Healing it Without Feeling itAccording to the Institute of Medicine, the numberof Americans who suffer from Chronic Pain isestimated to be: • 25 million • 45 million • 75 million • 100 million University Hospitals

  3. Objectives • Understand the basic principles of pain management • Understand the barriers to and myths of pain management • Understand regulations regarding prescribing/dispensing pain medications • Understand hospital specific resources for pain management October 27, 2012 University Hospitals University Hospitals

  4. Case presentation • CC: Fell off bicycle • HPI: 55yo WM competing in 4 day fundraising bicycle ride who fell off bicycle and now presenting with 10/10, constant, sharp, localized left hip pain. Patient has chronic tingling in hands and legs which is overshadowed by current pain. • PMH: OA- shoulders, spine, hips - s/p injections, wears soft cervical collar to sleep; Carpal Tunnel syndrome- wears wrist splints to sleep • NKDA October 27, 2012 University Hospitals University Hospitals

  5. Case presentation • Meds: • Pregabalin 100mg po TID x 2 years • Duloxetine 60mg po daily • Oxycontin 40mg po BID x 2years • Sennosides/ docusate 2 tabs po qhs • Cyclobenzaprine 5mg po qhs prn • FamHx: Non-contributory • SocHx: interventional radiologist, swims and/or bicycle rides 6 days a week; married to PM&R MD; no known addiction history October 27, 2012 University Hospitals University Hospitals

  6. Case presentation • ROS: as per HPI, otherwise negative • PE: Afebrile, HR- 120, RR- 18, BP- 140/ 75 • Remarkable for externally rotated and shortened L LE with pain on hip flexion • Labs: BMP, CBC, INR, LFTs within normal limits • Imaging: Left sided intertrochanteric hip fracture • Plan in ED: • Ortho consultation • Pain control • Admit October 27, 2012 University Hospitals University Hospitals

  7. Question 1You recognize patient is not opiate naïve. You need to give him something for pain. He is NPO for possible surgery. A reasonable first dose would be: A) Morphine 5mg IV B) Hydromorphone 2mg IV C) Oxycodone 5mg po D) Ketorolac 30mg IV • Patient’s Home Meds: • Pregabalin 100mg po TID x 2 years • Duloxetine 60mg po daily • Oxycontin 40mg po BID x 2years • Sennosides/ docusate 2 tabs po qhs • Cyclobenzaprine 5mg po qhs prn University Hospitals

  8. Best response: A • Route of choice • Drug of choice • Dose of choice • Acute on chronic pain- chronic pain meds are now baseline/ background • Convention in terms of reasonable breakthrough dose- 5-15% of daily long-acting • Must calculate equianalgesic doses A) Morphine 5mg IV B) Hydromorphone 2mg IV C) Oxycodone 5mg po D) Ketorolac 30mg IV October 27, 2012 University Hospitals University Hospitals

  9. Equianalgesic Dosing October 27, 2012 University Hospitals University Hospitals

  10. Question 2He is admitted with plans for surgery the next day. You need to control his pain overnight. The most reasonable option is: A) Morphine 5mg IV q4h prn B) Continue Oxycontin and Pregabalin and add Morphine 5mg IV q4h prn C) Continue Oxycontin and Pregabalin and add Morphine PCA University Hospitals

  11. Best response:C Practical aspects of choosing prn pain meds • Is patient going to be able to ask? • Will patient ask? • Is RN going to be able to get to patient in a timely manner? • Do we need to do some dose finding? • Pharmocokinetics A) Morphine 5mg IV q4h prn B) Continue Oxycontin and Pregabalin and add Morphine 5mg IV q4h prn C) Continue Oxycontin and Pregabalin and add Morphine PCA October 27, 2012 University Hospitals University Hospitals

  12. Best response:C Practical aspects of choosing to use a PCA • Is patient going to be able to safely use PCA? (not delirious, using opiates appropriately) • Do we need to do some dose finding? • We use less opiate with PCA than without • Continuous aspect of PCA- is equivalent to long-acting opiate • How to do PCA dosing - continuous, patient push and RN bolus A) Morphine 5mg IV q4h prn B) Continue Oxycontin and Pregabalin and add Morphine 5mg IV q4h prn C) Continue Oxycontin and Pregabalin and add Morphine PCA October 27, 2012 University Hospitals University Hospitals

  13. Best response:C • Takes more medicine to get pain under control than to keep it under control • Delirium in hip fractures more often from pain than opiates* * Relationship between Pain and Opioid Analgesics on the Development of Delirium Following Hip Fracture. Morrison et. al, Journal of Gerontology : Medical Sciences 2003, Vol. 58A, No. 1, 76-81. A) Morphine 5mg IV q4h prn B) Continue Oxycontin and Pregabalin and add Morphine 5mg IV q4h prn C) Continue Oxycontin and Pregabalin and add Morphine PCA October 27, 2012 University Hospitals University Hospitals

  14. Question 3Patient is now post-op. Continues to use PCA. He has fallen asleep. Nurse is concerned that his cell phone rings and he sleeps right through it. The nurse notifies you of this. You should: A) Give all the Narcan you can find on the floor B) Discontinue all opiates C) Hold opiates and restart at lower dose D) Assess patient and develop a ddx for the patient’s sedation University Hospitals

  15. Best responses:C & D • There is no set amount of opiate associated with sedation, respiratory arrest/ death • You get sedation first- safety of PCA with no continuous dosing (see graph) • RR drops slowly- not abrupt cessation of breathing • Catching up on sleep A) Give all the Narcan you can find on the floor B) Discontinue all opiates C) Hold opiates and restart at lower dose D) Assess patient and develop a ddx for the patient’s sedation October 27, 2012 University Hospitals University Hospitals

  16. Safety mechanism of PCAs with NO CONTINUOUS DOSE October 27, 2012 University Hospitals University Hospitals

  17. Best responses:C & D • Don’t want to get behind on pain which will happen if holding long-acting med --- liken this to other scheduled meds (e.g. beta blockers) • Abbey Pain Scale or other for assessing pain in non-communicative patient A) Give all the Narcan you can find on the floor B) Discontinue all opiates C) Hold opiates and restart at lower dose D) Assess patient and develop a ddx for the patient’s sedation October 27, 2012 University Hospitals University Hospitals

  18. Assessing Pain in Patients Who Can’t Communicate -Abbey Pain Scale October 27, 2012 University Hospitals University Hospitals

  19. Question 4Hospital day 3Patient’s pain is well controlled. He is doing well with PT and is going to be discharged home with home PT. He has had no BM since admission. What do we need to think of before he goes home? A) Which intern is responsible for d/c summary B) What his opiate dose will be C) What adjuvants he should be on D) What resources are available to him and you as you continue to manage his pain E) Who do we need to give a handoff to F) Fixing his constipation G) All of the above University Hospitals

  20. Best response:G Opiate dosing • Long-acting is 50-75% of total daily Oral Morphine Equivalent • varies for incident pain, expected changes to pain • Short-acting dose • Convention in terms of reasonable breakthrough dose - 5-15% of daily long-acting A) Which intern is responsible for d/c summary B) What his opiate dose will be C) What adjuvants he should be on D) What resources are available to him and you as you continue to manage his pain E) Who do we need to give a handoff to F) Fixing his constipation G) all of the above October 27, 2012 University Hospitals University Hospitals

  21. Basic Principles of Opiate Prescribing • Make it simple: oral route, one drug • Prescribe an adequate dose • Do the math! Use equianalgesic conversion table • Use a correct dosing interval • Prescribe around-the-clock (long-acting opiate) - when warranted • Provide a breakthrough dose (short-acting opiate) • Treat common opiate side effects • Use appropriate adjuvants October 27, 2012 University Hospitals University Hospitals

  22. Do the math! • Calculate 24 hour oral morphine equivalent (OME) • Consider adequacy of pain control • Calculate - expected total oral morphine equivalent • Increase current 24 hr OME by 25-50% for moderate pain control • Increase current 24 hr OME by 50-100% for poor pain control • Determine the opiate that will be given • Use equianalgesic conversion table • Correct for incomplete cross-tolerance when rotating to different opiate • Reduce dose by 25 – 50 % • Calculate short and long-acting doses October 27, 2012 University Hospitals University Hospitals

  23. Equianalgesic Dosing October 27, 2012 University Hospitals University Hospitals

  24. Best response:G ADJUVANTS • Inflammation/ post-op -NSAIDS/ steroids • Neuropathic – TCA, anti-epileptics, SNRI, anesthetics • Complementary therapies - heat/ice, massage, physical therapy, acupuncture etc. A) Which intern is responsible for d/c summary B) What his opiate dose will be C) what adjuvants he should be on D) What resources are available to him and you as you continue to manage his pain E) Who do we need to give a handoff to F) Fixing his constipation G) all of the above October 27, 2012 University Hospitals University Hospitals

  25. Best response:G • Talk to Team assuming care - re: course and plan for meds and what is being written for at d/c A) Which intern is responsible for d/c summary B) What his opiate dose will be C) What adjuvants he should be on D) What resources are available to him and you as you continue to manage his pain E) Who do we need to give a handoff to F) Fixing his constipation G) all of the above October 27, 2012 University Hospitals University Hospitals

  26. Guidelines for Dictating Pain Management History • Describe pain syndromes patient suffered • For each complaint, describe: • Type of pain and severity reported • Provoking factors • Relieving factors • Procedures completed/ attempted and result • Medications tried, what worked and at what dose • Medications tried that were ineffective • Medications with adverse reactions, how treated (remember to distinguish intolerance, such as nausea or sedation, from true allergy) University Hospitals

  27. Guidelines for Dictating Pain Management History Detailed description of • Discussion with patient and family on how to manage analgesics after discharge • Prescriptions given, including # of pills of each Rx and whether any refills were authorized • What doctor or doctors will be responsible for follow-up • If appropriate, what OARRS or pharmacy investigation was done • If appropriate, what REMS information was given to patient and whether a contract was or should be made for use of long-acting opiates in chronic non-cancer pain syndromes University Hospitals

  28. Definition of Terms • Use of a medication (for a medical purpose) other than as directed or as indicated, whether willful or unintentional, and whether harm results or not Misuse • Any use of an illegal drug • The intentional self administration of a medication for a nonmedical purpose such as altering one’s state of consciousness, eg, getting high Abuse • A primary, chronic, neurobiological disease, with genetic, psychosocial, and environmental factors influencing its development and manifestations • Behavioral characteristics include one or more of the following: impaired control over drug use, compulsive use, continued use despite harm, craving Addiction • Syndrome of abnormal behavior resulting from undertreatment of pain that is misidentified by the clinician as inappropriate drug-seeking behavior • Behavior ceases when adequate pain relief is provided • Not a diagnosis; rather, a description of the clinical intention Pseudoaddiction Katz NP, et al. Clin J Pain. 2007;23:648-660. October 27, 2012 University Hospitals University Hospitals

  29. Definition of Terms • A physiological state of neuro-adaptation which is characterized by WITHDRAWAL if…The drug is stopped, the drug is decreased abruptly, an antagonist is administered • The need to increase the dose of opioids to achieve the same level of analgesia Dependence Tolerance Katz NP, et al. Clin J Pain. 2007;23:648-660. October 27, 2012 University Hospitals University Hospitals

  30. FDA – REMS(Risk Evaluation and Mitigation Strategy) • Are regulatory requirements on medications that have a high threshold potential for harm • The FDA mandates that the Drug manufacturer develop a REMS program in order to continue sale of those medications • REMS programs may include any of the 4 following components: • Medication Guide • Communication Plan • Elements to Assure Safe Use (ETASU) • Implementation System • ETASU requires practitioners to complete one or all of the following: Prescriber Certification: Register and obtain/renew by completing drug company online training Medication Guide: Must be provided to all inpatients as well as outpatients prior to receiving the first dose Register the Patient Patient informed consent: Must be signed prior to administration of the drug October 27, 2012 University Hospitals University Hospitals

  31. FDA – REMS(Risk Evaluation and Mitigation Strategy) Some commonly used ETASU drugs • Oxycontin (soon to be all extended release narcotics) • Epogen/Procrit (ESA non-ESRD use) • Aranesp (ESA non-ESRD use) • Avandia • Zyprexa Relprevv • Entereg • Revlimid • Lumizyme • Tikosyn University Hospitals

  32. FDA – REMS October 27, 2012 University Hospitals University Hospitals

  33. WHERE TO FIND UH OPIOID GUIDELINES, ED OPIOID GUIDELINES and PAIN MANAGEMENT AGREEMENT University Hospitals

  34. Pain Management Referral Resources • General: Fast Facts- http://www.eperc.mcw.edu/EPERC/FastFactsandConcepts UH System Referral Resources October 27, 2012 University Hospitals University Hospitals

  35. Thank You. References: American Academy of Pain – Facts and Figures on Pain http://www.painmed.org/patientcenter/facts_on_pain.aspx Relationship between Pain and Opioid Analgesics on the Development of Delirium Following Hip Fracture, Morrison et al. Journal of Gerontology Medical Sciences 2003, Vol. 58A, No. 1, 76-81. The Abbey pain scale: a 1-minute numerical indicator for people with end-stage dementia, Abbey et al. Int Journal of Palliat Nurs 2004 Jan;10(1):6-13 Definition of Terms, Katz NP, et al. Clin J Pain. 2007;23:648-660 October 27, 2012 University Hospitals University Hospitals

More Related